Literature DB >> 12871329

Endogenous plasmin converts Glu-plasminogen to Lys-plasminogen on the monocytoid cell surface.

L Zhang1, Y Gong, D K Grella, F J Castellino, L A Miles.   

Abstract

Recently, we showed that localization of Glu-plasminogen on cell surfaces enhances its conversion to Lys-plasminogen by exogenous plasmin. This leads to stimulation of plasminogen activation because Lys-plasminogen is the preferred substrate on cell surfaces. Here, we show that Glu-plasminogen was converted to Lys-plasminogen on monocytoid cells in the absence of exogenous plasmin. Culture of cells under serum-free conditions did not affect this conversion, suggesting that the enzymatic activity was cell-derived. Therefore, we tested whether endogenous monocytoid plasminogen could provide a source of plasmin to convert cell-associated Glu-plasminogen to Lys-plasminogen because plasmin is the only enzyme known to effect this reaction. We used a recombinant human plasminogen mutant, [D(646)E]Pg, which can be cleaved by plasminogen activators, but cannot catalyze the generation of Lys-plasminogen. Upon incubation with either THP-1 or U937 monocytoid cells, 35 and 38%, respectively, of the cell-bound ligand was converted to Lys-[D(646)E]Pg. Trasylol, alpha2-antiplasmin, and an anticatalytic antiplasminogen monoclonal antibody decreased Lys-[D(646)E]Pg formation to < 5% on monocytoid cells, consistent with a plasmin-dependent mechanism. Plasminogen was detected in these cells by Northern blotting and RT-PCR. Our results suggest that plasmin converts cell-bound Glu-plasminogen to Lys-plasminogen and that this enzyme is produced by activation of monocytoid plasminogen by endogenous monocytoid plasminogen activators to enhance plasminogen activation on the monocytoid cell surface.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12871329     DOI: 10.1046/j.1538-7836.2003.00155.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  13 in total

1.  Monoclonal antibodies detect receptor-induced binding sites in Glu-plasminogen.

Authors:  Jaena Han; Nagyung Baik; Kee-Hwan Kim; Jian-Ming Yang; Gye Won Han; Yun Gong; Mercè Jardí; Francis J Castellino; Jordi Felez; Robert J Parmer; Lindsey A Miles
Journal:  Blood       Date:  2011-06-16       Impact factor: 22.113

2.  Plasmin-mediated proteolysis of human factor IXa in the presence of calcium/phospholipid: Conversion of procoagulant factor IXa to a fibrinolytic enhancer.

Authors:  Amy E Schmidt; Kanagasabai Vadivel; Julian Whitelegge; Satya Paul Bajaj
Journal:  J Thromb Haemost       Date:  2020-03-30       Impact factor: 5.824

Review 3.  Functions of the plasminogen receptor Plg-RKT.

Authors:  Lindsey A Miles; Juliana P Vago; Lirlândia P Sousa; Robert J Parmer
Journal:  J Thromb Haemost       Date:  2020-08-19       Impact factor: 5.824

4.  Engineering streptokinase for generation of active site-labeled plasminogen analogs.

Authors:  Malabika Laha; Peter Panizzi; Matthias Nahrendorf; Paul E Bock
Journal:  Anal Biochem       Date:  2011-04-23       Impact factor: 3.365

5.  Plasmin and regulators of plasmin activity control the migratory capacity and adhesion of human T cells and dendritic cells by regulating cleavage of the chemokine CCL21.

Authors:  Natalie Lorenz; Evert Jan Loef; Inken D Kelch; Daniel J Verdon; Moyra M Black; Martin J Middleditch; David R Greenwood; E Scott Graham; Anna Es Brooks; P Rod Dunbar; Nigel P Birch
Journal:  Immunol Cell Biol       Date:  2016-06-15       Impact factor: 5.126

Review 6.  Proteases as therapeutics.

Authors:  Charles S Craik; Michael J Page; Edwin L Madison
Journal:  Biochem J       Date:  2011-04-01       Impact factor: 3.857

Review 7.  New insights into the role of Plg-RKT in macrophage recruitment.

Authors:  Lindsey A Miles; Shahrzad Lighvani; Nagyung Baik; Caitlin M Parmer; Sophia Khaldoyanidi; Barbara M Mueller; Robert J Parmer
Journal:  Int Rev Cell Mol Biol       Date:  2014       Impact factor: 6.813

Review 8.  Plasminogen receptors: the first quarter century.

Authors:  Lindsey A Miles; Robert J Parmer
Journal:  Semin Thromb Hemost       Date:  2013-03-26       Impact factor: 4.180

9.  Design of a DNA-Programmed Plasminogen Activator.

Authors:  Purba Mukherjee; Luke J Leman; John H Griffin; M Reza Ghadiri
Journal:  J Am Chem Soc       Date:  2018-11-01       Impact factor: 15.419

10.  Plasminogen inhibits TNFalpha-induced apoptosis in monocytes.

Authors:  Jennifer W Mitchell; Nagyung Baik; Francis J Castellino; Lindsey A Miles
Journal:  Blood       Date:  2006-02-14       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.